A-24

Agrostis Gigantea Pollen, Festuca Pratensis Pollen, Poa Pratensis Pollen, Dactylis Glomerata Pollen, Phleum Pratense Pollen, Anthoxanthum Odoratum Pollen, Lolium Perenne Pollen, Medicago Sativa Pollen, Trifolium Pratense Pollen, Solidago Canadensis Pollen, Ambrosia Acanthicarpa Pollen, Ambrosia Psilostachya Pollen, Ambrosia Trifida Pollen, Ambrosia Artemisiifolia Pollen, Xanthium Strumarium Pollen, Chenopodium Album Pollen, Amaranthus Retroflexus Pollen, And Cynodon Dactylon Pollen

Dna Labs, Inc.
Human Otc Drug
NDC 58264-0329

A-24 also known as Agrostis Gigantea Pollen, Festuca Pratensis Pollen, Poa Pratensis Pollen, Dactylis Glomerata Pollen, Phleum Pratense Pollen, Anthoxanthum Odoratum Pollen, Lolium Perenne Pollen, Medicago Sativa Pollen, Trifolium Pratense Pollen, Solidago Canadensis Pollen, Ambrosia Acanthicarpa Pollen, Ambrosia Psilostachya Pollen, Ambrosia Trifida Pollen, Ambrosia Artemisiifolia Pollen, Xanthium Strumarium Pollen, Chenopodium Album Pollen, Amaranthus Retroflexus Pollen, And Cynodon Dactylon Pollen is a human otc drug labeled by 'Dna Labs, Inc.'. National Drug Code (NDC) number for A-24 is 58264-0329. This drug is available in dosage form of Solution. The names of the active, medicinal ingredients in A-24 drug includes Agrostis Gigantea Pollen - 30 [hp_X]/mL Amaranthus Retroflexus Pollen - 30 [hp_X]/mL Ambrosia Acanthicarpa Pollen - 30 [hp_X]/mL Ambrosia Artemisiifolia Pollen - 30 [hp_X]/mL Ambrosia Psilostachya Pollen - 30 [hp_X]/mL Ambrosia Trifida Pollen - 30 [hp_X]/mL Anthoxanthum Odoratum Pollen - 30 [hp_X]/mL Chenopodium Album Pollen - 30 [hp_X]/mL Cynodon Dactylon Pollen - 30 [hp_X]/mL Dactylis Glomerata Pollen - 30 [hp_X]/mL and more. The currest status of A-24 drug is Active.

Drug Information:

Drug NDC:	58264-0329
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	A-24
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Agrostis Gigantea Pollen, Festuca Pratensis Pollen, Poa Pratensis Pollen, Dactylis Glomerata Pollen, Phleum Pratense Pollen, Anthoxanthum Odoratum Pollen, Lolium Perenne Pollen, Medicago Sativa Pollen, Trifolium Pratense Pollen, Solidago Canadensis Pollen, Ambrosia Acanthicarpa Pollen, Ambrosia Psilostachya Pollen, Ambrosia Trifida Pollen, Ambrosia Artemisiifolia Pollen, Xanthium Strumarium Pollen, Chenopodium Album Pollen, Amaranthus Retroflexus Pollen, And Cynodon Dactylon Pollen
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Dna Labs, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Solution
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	AGROSTIS GIGANTEA POLLEN - 30 [hp_X]/mL AMARANTHUS RETROFLEXUS POLLEN - 30 [hp_X]/mL AMBROSIA ACANTHICARPA POLLEN - 30 [hp_X]/mL AMBROSIA ARTEMISIIFOLIA POLLEN - 30 [hp_X]/mL AMBROSIA PSILOSTACHYA POLLEN - 30 [hp_X]/mL AMBROSIA TRIFIDA POLLEN - 30 [hp_X]/mL ANTHOXANTHUM ODORATUM POLLEN - 30 [hp_X]/mL CHENOPODIUM ALBUM POLLEN - 30 [hp_X]/mL CYNODON DACTYLON POLLEN - 30 [hp_X]/mL DACTYLIS GLOMERATA POLLEN - 30 [hp_X]/mL Load more... FESTUCA PRATENSIS POLLEN - 30 [hp_X]/mL LOLIUM PERENNE POLLEN - 30 [hp_X]/mL MEDICAGO SATIVA POLLEN - 30 [hp_X]/mL PHLEUM PRATENSE POLLEN - 30 [hp_X]/mL POA PRATENSIS POLLEN - 30 [hp_X]/mL SOLIDAGO CANADENSIS POLLEN - 30 [hp_X]/mL SORGHUM HALEPENSE POLLEN - 30 [hp_X]/mL TRIFOLIUM PRATENSE POLLEN - 30 [hp_X]/mL XANTHIUM STRUMARIUM POLLEN - 30 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	01 Jan, 1990
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	24 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	DNA Labs, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
NUI:	N0000185006 N0000185367 N0000175629 N0000184306 N0000185001 M0017130 M0000728
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	HU8V6E7HOA 73B14PX5FW U2AI3H2J5Y K20Y81ACO3 RX18M46K8L KU1V1898XX 2KIK19R45Y 098LKX5NCN 175F461W10 83N78IDA7P Load more... A0WFQ8P6N1 4T81LB52R0 G515RAI9FY 65M88RW2EG SCB8J7LS3T 644CZ16IR5 577VA5B4HP 3SNK70F46Y 2QOF601J1M
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:	Standardized Pollen Allergenic Extract [EPC] Non-Standardized Pollen Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:	Increased Histamine Release [PE] Cell-mediated Immunity [PE] Increased IgG Production [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:	Pollen [CS] Allergens [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Allergens [CS] Cell-mediated Immunity [PE] Increased Histamine Release [PE] Increased IgG Production [PE] Non-Standardized Pollen Allergenic Extract [EPC] Pollen [CS] Standardized Pollen Allergenic Extract [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
58264-0329-1	29.57 mL in 1 BOTTLE, GLASS (58264-0329-1)	01 Jan, 1990	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

A-24

Agrostis Gigantea Pollen & more..

Solution
DNA Labs, Inc.
NDC: 58264-0329

Purpose:

Allergies.

Product Elements:

A-24 agrostis gigantea pollen, festuca pratensis pollen, poa pratensis pollen, dactylis glomerata pollen, phleum pratense pollen, anthoxanthum odoratum pollen, lolium perenne pollen, medicago sativa pollen, trifolium pratense pollen, solidago canadensis pollen, ambrosia acanthicarpa pollen, ambrosia psilostachya pollen, ambrosia trifida pollen, ambrosia artemisiifolia pollen, xanthium strumarium pollen, chenopodium album pollen, amaranthus retroflexus pollen, and cynodon dactylon pollen alcohol water agrostis gigantea pollen agrostis gigantea pollen festuca pratensis pollen festuca pratensis pollen poa pratensis pollen poa pratensis pollen dactylis glomerata pollen dactylis glomerata pollen phleum pratense pollen phleum pratense pollen phleum pratense top anthoxanthum odoratum pollen anthoxanthum odoratum pollen lolium perenne pollen lolium perenne pollen medicago sativa pollen medicago sativa pollen trifolium pratense pollen trifolium pratense pollen solidago canadensis pollen solidago canadensis pollen ambrosia acanthicarpa pollen ambrosia acanthicarpa pollen ambrosia psilostachya pollen ambrosia psilostachya pollen ambrosia trifida pollen ambrosia trifida pollen ambrosia artemisiifolia pollen ambrosia artemisiifolia pollen xanthium strumarium pollen xanthium strumarium pollen chenopodium album pollen chenopodium album pollen amaranthus retroflexus pollen amaranthus retroflexus pollen cynodon dactylon pollen cynodon dactylon pollen sorghum halepense pollen sorghum halepense pollen

Indications and Usage:

Indications allergies.

Warnings:

Warnings use only if cap seal is unbroken. if pregnant or breastfeeding, ask a healthcare professional before use. keep this and all medication out of the reach of children.

Dosage and Administration:

Suggested dosage normal dose for the first week is 2-3 drops in water t.i.d. add one drop per dose per week until a total of ten drops is reached.

Package Label Principal Display Panel:

Principal display panel - 1 fl. oz. bottle label dynamic nutritional associates, inc. a-24 pollen mix #1 homeopathic antigen 1 fl. oz. a-24

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.